Fereshteh Rastegarnasab (Fereshte Rastegarnasab)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Respiratory Syndrome Coronavirus

Spectrum Disorder

Allergic Rhinitis

Top Venues

Journal of cosmetic dermatology

International wound journal

Clinical case reports

Case reports in dermatological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nahid Aslani, Bahareh Abtahi-Naeini, Fereshteh Rastegarnasab, Maryam Derakhshan, Elham Tavousi, Kimia Mehraein
Combination of four features of SLC29A3 spectrum disorder in a child: A case report. Pediatric dermatology (2024)
Bahareh Abtahi-Naeini, Elahe Hemati, Gita Faghihi, Zabihollah Shahmoradi, Fatemeh Paknazar, Fereshteh Rastegarnasab, Jaleh Varshosaz, Mahdi Hadian, Mojtaba Akbari, Ali Mohammad Sabzghabaee
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial. Journal of cosmetic dermatology 23 (5) (2024)
Bahareh Abtahi-Naeini, Elahe Hemati, Gita Faghihi, Zabihollah Shahmoradi, Fatemeh Paknazar, Fereshteh Rastegarnasab, Jaleh Varshosaz, Mahdi Hadian, Mojtaba Akbari, Ali Mohammad Sabzghabaee
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial. Journal of cosmetic dermatology 23 (5) (2024)
Bahareh Abtahi-Naeini, Elahe Hemati, Gita Faghihi, Zabihollah Shahmoradi, Fatemeh Paknazar, Fereshteh Rastegarnasab, Jaleh Varshosaz, Mahdi Hadian, Mojtaba Akbari, Ali Mohammad Sabzghabaee
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial. Journal of cosmetic dermatology 23 (5) (2024)
Bahareh Abtahi-Naeini, Elahe Hemati, Gita Faghihi, Zabihollah Shahmoradi, Fatemeh Paknazar, Fereshteh Rastegarnasab, Jaleh Varshosaz, Mahdi Hadian, Mojtaba Akbari, Ali Mohammad Sabzghabaee
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial. Journal of cosmetic dermatology (2024)
Bahareh Abtahi-Naeini, Zahra Pourmoghaddas, Fereshteh Rastegarnasab, Fateme Ahmadinia
Unusual cause of a large wound on the leg: PG-like cutaneous leishmaniasis. International wound journal (2023)
Saeedeh Farajzadeh, Maryam Khalili, Majid Mirmohammadkhani, Fatemeh Paknazar, Fereshteh Rastegarnasab, Bahareh Abtahi-Naeini
Global clinicoepidemiological pattern of childhood vitiligo: a systematic review and meta-analysis. BMJ paediatrics open 7 (1) (2023)
Bahram Eshraghi, Sarah Ghorbani, Mohsen Pourazizi, Maryam Derakhshan, Fereshteh Rastegarnasab, Bahareh Abtahi-Naeini
Unusual cause of bilateral periocular ulceronecrotic wound: Tetracaine abuse-associated bullous drug eruption. International wound journal (2023)
Bahareh Abtahi-Naeini, Atefeh Payandeh, Fereshteh Rastegarnasab
Successful treatment of fungal ball-associated tinea capitis in a healthy infant: An unusual presentation. Clinical case reports 11 (8) (2023)
Bahareh Abtahi-Naeini, Tooba Momen, Rezvan Amiri, Parvin Rajabi, Fereshteh Rastegarnasab
Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review. Case reports in dermatological medicine 2023 (2023)
Maryam Khalili, Bahareh Abtahi-Naeini, Fereshteh Rastegarnasab, Kimia Afshar
COVID-19-associated pityriasis rosea in children: Case report and literature review. Clinical case reports 10 (7) (2022)
Bahareh Abtahi-Naeini, Tooba Momen, Shakiba Dehghani, Fereshteh Rastegarnasab
An unusual cause of facial wound in a child: Hyper IgE syndrome-associated Noma neonatorum. International wound journal 19 (8) (2022)
Bahareh Abtahi-Naeini, Fereshteh Rastegarnasab, Ali Saffaei
Liquid vitamin E injection for cosmetic facial rejuvenation: A disaster report of lipogranuloma. Journal of cosmetic dermatology (2022)
Zahra Pourmoghaddas, Fereshteh Rastegarnasab, Ali Mohammad Sabzghabaee, Bahareh Abtahi-Naeini
Scalp necrotic wound and hyperinflammatory shock related to COVID-19: Topical sucralfate as a promising topical agent. International wound journal (2022)